Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Guiding Dose Increases in Patients Incompletely Responsive to Usual Doses of Atomoxetine

This study has been completed.
Information provided by:
Eli Lilly and Company Identifier:
First received: June 11, 2007
Last updated: October 31, 2007
Last verified: June 2007
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2005
  Estimated Primary Completion Date: No date given